Early studies using serum-derived antibodies from PCD patients localized the Yo antigen to ribosomes and rough endoplasmic reticulum [13, 14], thereby providing the first indications that CDR2L, the major antigen of anti-Yo antibodies [11], was a regulator of protein synthesis. The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.